Cydney L Rios
Overview
Explore the profile of Cydney L Rios including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
704
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sajuthi S, Everman J, Jackson N, Saef B, Rios C, Moore C, et al.
Nat Commun
. 2022 Oct;
13(1):5806.
PMID: 36192399
No abstract available.
2.
Sajuthi S, Everman J, Jackson N, Saef B, Rios C, Moore C, et al.
Nat Commun
. 2022 Mar;
13(1):1632.
PMID: 35347136
To identify genetic determinants of airway dysfunction, we performed a transcriptome-wide association study for asthma by combining RNA-seq data from the nasal airway epithelium of 681 children, with UK Biobank...
3.
Sajuthi S, DeFord P, Li Y, Jackson N, Montgomery M, Everman J, et al.
Nat Commun
. 2020 Oct;
11(1):5139.
PMID: 33046696
Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, an emerging virus that utilizes host proteins ACE2 and TMPRSS2 as entry factors. Understanding the factors affecting the pattern and levels of...
4.
Jackson N, Everman J, Chioccioli M, Feriani L, Goldfarbmuren K, Sajuthi S, et al.
Cell Rep
. 2020 Jul;
32(1):107872.
PMID: 32640237
The type 2 cytokine-high asthma endotype (T2H) is characterized by IL-13-driven mucus obstruction of the airways. To further investigate this incompletely understood pathobiology, we characterize IL-13 effects on human airway...
5.
Sajuthi S, DeFord P, Jackson N, Montgomery M, Everman J, Rios C, et al.
bioRxiv
. 2020 Jun;
PMID: 32511326
Coronavirus disease 2019 (COVID-19) outcomes vary from asymptomatic infection to death. This disparity may reflect different airway levels of the SARS-CoV-2 receptor, ACE2, and the spike protein activator, TMPRSS2. Here...
6.
Goldfarbmuren K, Jackson N, Sajuthi S, Dyjack N, Li K, Rios C, et al.
Nat Commun
. 2020 May;
11(1):2485.
PMID: 32427931
Cigarette smoke first interacts with the lung through the cellularly diverse airway epithelium and goes on to drive development of most chronic lung diseases. Here, through single cell RNA-sequencing analysis...
7.
Peters M, Sajuthi S, DeFord P, Christenson S, Rios C, Montgomery M, et al.
Am J Respir Crit Care Med
. 2020 Apr;
202(1):83-90.
PMID: 32348692
Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). ACE2 (angiotensin-converting enzyme 2), and TMPRSS2 (transmembrane protease serine 2) mediate viral infection of host cells. We...
8.
Montgomery M, Sajuthi S, Cho S, Everman J, Rios C, Goldfarbmuren K, et al.
Am J Respir Cell Mol Biol
. 2020 Apr;
63(2):172-184.
PMID: 32275839
Air pollution particulate matter <2.5 μm (PM) exposure is associated with poor respiratory outcomes. Mechanisms underlying PM-induced lung pathobiology are poorly understood but likely involve cellular and molecular changes to...
9.
Gordon E, Palandra J, Wesolowska-Andersen A, Ringel L, Rios C, Lachowicz-Scroggins M, et al.
JCI Insight
. 2016 Oct;
1(14):e87871.
PMID: 27699235
Genome-wide association studies of asthma have identified genetic variants in the gene, but the molecular mechanisms conferring risk are unknown. encodes the ST2 receptor (ST2L) for IL-33 and an inhibitory...
10.
Gordon E, Simpson L, Rios C, Ringel L, Lachowicz-Scroggins M, Peters M, et al.
Proc Natl Acad Sci U S A
. 2016 Jul;
113(31):8765-70.
PMID: 27432971
Type 2 inflammation occurs in a large subgroup of asthmatics, and novel cytokine-directed therapies are being developed to treat this population. In mouse models, interleukin-33 (IL-33) activates lung resident innate...